Publications

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

 28
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ- derived CD47 blocker

Tags:

Previous Article

Broadly neutralizing antibodies against emerging delta-coronaviruses

Next Article

Immunotherapy for glioblastoma and its microenvironment

Related Posts

Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment

Skin hepcidin initiates psoriasiform skin inflammation ...

 23

Targeting cholesterol-dependent adrenal steroidogenesis for management of primary aldosteronism

Targeting cholesterol-dependent adrenal steroidogenesis...

 22

Structural basis of Spliced Leader RNA recognition by the Trypanosoma brucei cap-binding complex

Structural basis of Spliced Leader RNA recognition by t...

 13